TherapeuticsMD, Inc. (TXMD) Total liabilities 2016–2025
TherapeuticsMD, Inc. (TXMD) total liabilities at each fiscal year-end, per SEC filings.
$10.8MFY2025 · since FY2016: $15.0M → $10.8M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $10.8M | -5.9% |
| FY2024 | $11.5M | -18.3% |
| FY2023 | $14.0M | -74.7% |
| FY2022 | $55.3M | -79.0% |
| FY2021 | $263.1M | -13.9% |
| FY2020 | $305.6M | +19.0% |
| FY2019 | $256.8M | +124.3% |
| FY2018 | $114.5M | +759.2% |
| FY2017 | $13.3M | -11.1% |
| FY2016 | $15.0M | — |
Years the filer does not tag total liabilities directly are shown as reported total assets − reported shareholders’ equity at the same fiscal year-end.
Source: SEC XBRL filings · For reference only · Not investment advice
More TXMD financial trends
TXMD RevenueTXMD Net incomeTXMD Net marginTXMD Gross profitTXMD Gross marginTXMD Operating incomeTXMD Operating marginTXMD Operating cash flowTXMD Free cash flowTXMD Capital expendituresTXMD Return on equityTXMD Stock buybacksTXMD Dividends paidTXMD Total assetsTXMD Shareholders’ equityTXMD overview →